BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32703192)

  • 1. Attenuation of intestinal inflammation in IL-10 deficient mice by a plasmid carrying Lactococcus lactis strain.
    Zurita-Turk M; Mendes Souza B; Prósperi de Castro C; Bastos Pereira V; Pecini da Cunha V; Melo Preisser T; Caetano de Faria AM; Carmona Cara Machado D; Miyoshi A
    BMC Biotechnol; 2020 Jul; 20(1):38. PubMed ID: 32703192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactococcus lactis carrying the pValac DNA expression vector coding for IL-10 reduces inflammation in a murine model of experimental colitis.
    Zurita-Turk M; Del Carmen S; Santos AC; Pereira VB; Cara DC; Leclercq SY; de LeBlanc Ad; Azevedo V; Chatel JM; LeBlanc JG; Miyoshi A
    BMC Biotechnol; 2014 Aug; 14():73. PubMed ID: 25106058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactococcus lactis carrying the pValac eukaryotic expression vector coding for IL-4 reduces chemically-induced intestinal inflammation by increasing the levels of IL-10-producing regulatory cells.
    Souza BM; Preisser TM; Pereira VB; Zurita-Turk M; de Castro CP; da Cunha VP; de Oliveira RP; Gomes-Santos AC; de Faria AM; Machado DC; Chatel JM; Azevedo VA; Langella P; Miyoshi A
    Microb Cell Fact; 2016 Aug; 15(1):150. PubMed ID: 27576902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant
    Preisser TM; da Cunha VP; Santana MP; Pereira VB; Cara DC; Souza BM; Miyoshi A
    J Diabetes Res; 2021; 2021():6697319. PubMed ID: 33604389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive Lactococcus lactis producing mycobacterial Hsp65 ameliorates intestinal inflammation in acute TNBS-induced colitis in mice by increasing the levels of the cytokine IL-10 and secretory IgA.
    da Cunha VP; Preisser TM; Santana MP; Machado DCC; Pereira VB; Miyoshi A
    J Appl Microbiol; 2020 Nov; 129(5):1389-1401. PubMed ID: 32473073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventative delivery of IL-35 by Lactococcus lactis ameliorates DSS-induced colitis in mice.
    Wang J; Tian M; Li W; Hao F
    Appl Microbiol Biotechnol; 2019 Oct; 103(19):7931-7941. PubMed ID: 31456001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the anti-inflammatory effect of milk fermented by a strain of IL-10-producing Lactococcus lactis using a murine model of Crohn's disease.
    del Carmen S; de Moreno de LeBlanc A; Perdigon G; Bastos Pereira V; Miyoshi A; Azevedo V; LeBlanc JG
    J Mol Microbiol Biotechnol; 2011; 21(3-4):138-46. PubMed ID: 22286041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactococcus lactis carrying a DNA vaccine coding for the ESAT-6 antigen increases IL-17 cytokine secretion and boosts the BCG vaccine immune response.
    Pereira VB; da Cunha VP; Preisser TM; Souza BM; Turk MZ; De Castro CP; Azevedo MSP; Miyoshi A
    J Appl Microbiol; 2017 Jun; 122(6):1657-1662. PubMed ID: 28314076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.
    Martín R; Chain F; Miquel S; Natividad JM; Sokol H; Verdu EF; Langella P; Bermúdez-Humarán LG
    Hum Vaccin Immunother; 2014; 10(6):1611-21. PubMed ID: 24732667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response elicited by DNA vaccination using Lactococcus lactis is modified by the production of surface exposed pathogenic protein.
    Pontes D; Azevedo M; Innocentin S; Blugeon S; Lefévre F; Azevedo V; Miyoshi A; Courtin P; Chapot-Chartier MP; Langella P; Chatel JM
    PLoS One; 2014; 9(1):e84509. PubMed ID: 24465412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterial Hsp65 antigen delivered by invasive Lactococcus lactis reduces intestinal inflammation and fibrosis in TNBS-induced chronic colitis model.
    da Cunha VP; Preisser TM; Santana MP; Machado DCC; Pereira VB; Miyoshi A
    Sci Rep; 2020 Nov; 10(1):20123. PubMed ID: 33208841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral Tolerance Induced by Heat Shock Protein 65-Producing
    Guerra PV; Andrade CM; Nunes IV; Gama BC; Tibúrcio R; Santos WLC; Azevedo VA; Tavares NM; Rebouças JS; Maiolii TU; Faria AMC; Brodskyn CI
    Front Immunol; 2021; 12():647987. PubMed ID: 34248935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization.
    Frossard CP; Steidler L; Eigenmann PA
    J Allergy Clin Immunol; 2007 Apr; 119(4):952-9. PubMed ID: 17316776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant invasive Lactococcus lactis can transfer DNA vaccines either directly to dendritic cells or across an epithelial cell monolayer.
    de Azevedo M; Meijerink M; Taverne N; Pereira VB; LeBlanc JG; Azevedo V; Miyoshi A; Langella P; Wells JM; Chatel JM
    Vaccine; 2015 Sep; 33(38):4807-12. PubMed ID: 26241952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein.
    Foligne B; Dessein R; Marceau M; Poiret S; Chamaillard M; Pot B; Simonet M; Daniel C
    Gastroenterology; 2007 Sep; 133(3):862-74. PubMed ID: 17678918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in mice.
    Hanson ML; Hixon JA; Li W; Felber BK; Anver MR; Stewart CA; Janelsins BM; Datta SK; Shen W; McLean MH; Durum SK
    Gastroenterology; 2014 Jan; 146(1):210-221.e13. PubMed ID: 24120477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a new DNA vaccine based on mycobacterial ESAT-6 antigen delivered by recombinant invasive Lactococcus lactis FnBPA+.
    Pereira VB; Saraiva TD; Souza BM; Zurita-Turk M; Azevedo MS; De Castro CP; Mancha-Agresti P; Dos Santos JS; Santos AC; Faria AM; Leclercq S; Azevedo V; Miyoshi A
    Appl Microbiol Biotechnol; 2015 Feb; 99(4):1817-26. PubMed ID: 25503506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal delivery of Lactococcus lactis carrying an anti-TNF scFv expression vector ameliorates experimental colitis in mice.
    Chiabai MJ; Almeida JF; de Azevedo MGD; Fernandes SS; Pereira VB; de Castro RJA; Jerônimo MS; Sousa IG; de Souza Vianna LM; Miyoshi A; Bocca AL; Maranhão AQ; Brigido MM
    BMC Biotechnol; 2019 Jun; 19(1):38. PubMed ID: 31238939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered and wild-type L. lactis promote anti-inflammatory cytokine signalling in inflammatory bowel disease patient's mucosa.
    Simčič S; Berlec A; Stopinšek S; Štrukelj B; Orel R
    World J Microbiol Biotechnol; 2019 Feb; 35(3):45. PubMed ID: 30810891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of Fibronectin Binding Protein A at the surface of Lactococcus lactis increases plasmid transfer in vitro and in vivo.
    Pontes D; Innocentin S; Del Carmen S; Almeida JF; Leblanc JG; de Moreno de Leblanc A; Blugeon S; Cherbuy C; Lefèvre F; Azevedo V; Miyoshi A; Langella P; Chatel JM
    PLoS One; 2012; 7(9):e44892. PubMed ID: 23028664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.